BOSTON, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that management will participate in one-on-one meetings at the upcoming Wells Fargo 21 st Annual Healthcare Conference, taking place September 8-10, 2026, in Boston, MA.
Globe Newswire
Original source
LINYI, China, Oct. 28, 2026 /PRNewswire/ -- A news report from chinadaily.com.cn: More than 2,000 overseas buyers from more than 110 countries and regions across Southeast Asia, Central Asia, Africa, and the Middle East are gathering in Linyi to attend the 4th Linyi Trade City...
LOS ANGELES, Oct 28 : Apple is expected to unveil its first touchscreen MacBooks on Wednesday, abandoning a long-held aversion to the technology as it caps a burst of product launches ahead of the crucial holiday shopping season. Apple is holding an event in Los Angeles after launching a folding iPhone, Duo, a
Each 6.9-inch internal diameter jumper will measure approximately 1,000 metres and operate at water depths exceeding 2,200 metres
Firms earning Dh50 million or more must appoint an accredited provider ahead of 2027 rollout
Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.
Read Disclaimer